WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 30, 2003, 23(17):6788-6792

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (38)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cataldo, A. M.
Right arrow Articles by Nixon, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cataldo, A. M.
Right arrow Articles by Nixon, R. A.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

Anne M. Cataldo,1,2,3 Suzana Petanceska,3 Corrinne M. Peterhoff,3 Nicole B. Terio,3 Charles J. Epstein,4 Angela Villar,4 Elaine J. Carlson,5 Matthias Staufenbiel,6 and Ralph A. Nixon3,7

1Mailman Research Center, McLean Hospital, Belmont, Massachusetts 02478, 2Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, 3Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York 10962, 4Department of Pediatrics, University of California, San Francisco, San Francisco, California 94143, 5Genomics Core Facility, University of California, San Francisco, San Francisco, California 94143, 6Novartis Institute of Biomedical Research, Nervous System, CH-4002 Basel, Switzerland, and 7Departments of Psychiatry and Cell Biology, New York University School of Medicine, New York, New York 10016

Altered neuronal endocytosis is the earliest known pathology in sporadic Alzheimer's disease (AD) and Down syndrome (DS) brain and has been linked to increased A{beta} production. Here, we show that a genetic model of DS (trisomy 21), the segmental trisomy 16 mouse Ts65Dn, develops enlarged neuronal early endosomes, increased immunoreactivity for markers of endosome fusion (rab5, early endosomal antigen 1, and rabaptin5), and endosome recycling (rab4) similar to those in AD and DS individuals. These abnormalities are most prominent in neurons of the basal forebrain, which later develop aging-related atrophy and degenerative changes, as in AD and DS. We also show that App, one of the triplicated genes in Ts65Dn mice and human DS, is critical to the development of these endocytic abnormalities. Selectively deleting one copy of App or a small portion of the chromosome 16 segment containing App from Ts65Dn mice eliminated the endosomal phenotype. Overexpressing App at high levels in mice did not alter early endosomes, implying that one or more additional genes on the triplicated segment of chromosome 16 are also required for the Ts65Dn endosomal phenotype. These results identify an essential role for App gene triplication in causing AD-related endosomal abnormalities and further establish the pathogenic significance of endosomal dysfunction in AD.

Key words: endosomes; endocytic pathway; Ts65Dn; Ts1Cje; Down syndrome; Alzheimer's disease; amyloid precursor protein; basal forebrain neurons


Received Apr. 7, 2003; revised Apr. 7, 2003; accepted May. 14, 2003.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K. T. Chang and K.-T. Min
Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: Implications for Down syndrome
PNAS, October 6, 2009; 106(40): 17117 - 17122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Thomas, B. Ritter, D. Verbich, C. Sanson, L. Bourbonniere, R. A. McKinney, and P. S. McPherson
Intersectin Regulates Dendritic Spine Development and Somatodendritic Endocytosis but Not Synaptic Vesicle Recycling in Hippocampal Neurons
J. Biol. Chem., May 1, 2009; 284(18): 12410 - 12419.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. Yu, P.-Y. Chu, D. N. Bowser, D. J. Keating, D. Dubach, I. Harper, J. Tkalcevic, D. I. Finkelstein, and M. A. Pritchard
Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities
Hum. Mol. Genet., November 1, 2008; 17(21): 3281 - 3290.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Cataldo, P. M. Mathews, A. B. Boiteau, L. C. Hassinger, C. M. Peterhoff, Y. Jiang, K. Mullaney, R. L. Neve, J. Gruenberg, and R. A. Nixon
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology: Accelerated Endocytosis Promotes Late Endocytic Defects
Am. J. Pathol., August 1, 2008; 173(2): 370 - 384.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. V. Voronov, S. G. Frere, S. Giovedi, E. A. Pollina, C. Borel, H. Zhang, C. Schmidt, E. C. Akeson, M. R. Wenk, L. Cimasoni, et al.
Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome
PNAS, July 8, 2008; 105(27): 9415 - 9420.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. J. Keating, D. Dubach, M. P. Zanin, Y. Yu, K. Martin, Y.-F. Zhao, C. Chen, S. Porta, M. L. Arbones, L. Mittaz, et al.
DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease
Hum. Mol. Genet., April 1, 2008; 17(7): 1020 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Schneider, L. Rajendran, M. Honsho, M. Gralle, G. Donnert, F. Wouters, S. W. Hell, and M. Simons
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
J. Neurosci., March 12, 2008; 28(11): 2874 - 2882.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-R. Ryoo, H. K. Jeong, C. Radnaabazar, J.-J. Yoo, H.-J. Cho, H.-W. Lee, I.-S. Kim, Y.-H. Cheon, Y. S. Ahn, S.-H. Chung, et al.
DYRK1A-mediated Hyperphosphorylation of Tau: A FUNCTIONAL LINK BETWEEN DOWN SYNDROME AND ALZHEIMER DISEASE
J. Biol. Chem., November 30, 2007; 282(48): 34850 - 34857.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
B. A. Tate and P. M. Mathews
Targeting the Role of the Endosome in the Pathophysiology of Alzheimer's Disease: A Strategy for Treatment
Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): re2 - re2.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Zhang, A. Haapasalo, D. Y. Kim, L. A. M. Ingano, W. H. Pettingell, and D. M. Kovacs
Presenilin/{gamma}-secretase activity regulates protein clearance from the endocytic recycling compartment
FASEB J, June 1, 2006; 20(8): 1176 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Langui, N. Girardot, K. H. El Hachimi, B. Allinquant, V. Blanchard, L. Pradier, and C. Duyckaerts
Subcellular Topography of Neuronal A{beta} Peptide in APPxPS1 Transgenic Mice
Am. J. Pathol., November 1, 2004; 165(5): 1465 - 1477.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. A. Nixon
Niemann-Pick Type C Disease and Alzheimer's Disease: The APP-Endosome Connection Fattens Up
Am. J. Pathol., March 1, 2004; 164(3): 757 - 761.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-